Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Abstract Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and…
clinical trials
New Prospect for Cancer Cachexia: Medical Cannabinoid
Abstract Cachexia is a common term for the wasting symptoms which may appear in almost every chronic illness, such as…
Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
Abstract Fragile X syndrome (FXS) is the leading known cause of inherited intellectual disability and autism spectrum disorder. It is…
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence
Abstract There is urgent need for the development of mechanistically different and less side-effect prone antipsychotic compounds. The endocannabinoid system…
Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
Abstract Cancer is the second leading cause of death in the United States with 1.7 million new cases estimated to…
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
Abstract This overview covers a wide range of cannabis topics, initially examining issues in dispensaries and self-administration, plus regulatory requirements…
Review of available studies of the neurobiology and pharmacotherapeutic management of trichotillomania
Keywords: Trichotillomania (TTM), Neurobiology, Rating scales, Clinical trials Authors: Jacklyn Johnson, Abir T. El-Alfy License: © 2015 Production and hosting…
Systematic review of herbals as potential anti-inflammatory agents: Recent advances, current clinical status and future perspectives
Abstract Many synthetic drugs reported to be used for the treatment of inflammatory disorders are of least interest now a…